homefeedbacksupportlog on 13-Oct-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Dermatology
Acquired & Inherited Bullous Disorders

profile subject selected for My F1000 Medicine

Browse > Dermatology > Acquired & Inherited Bullous Disorders
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals)
/ Most viewed
(from specialty journals)
/ Hidden jewels
Page 1 of 4. Select Page: 1 2 3 4 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Must Read
F1000 Factor 6.0

New Finding
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.
Matsushita T, Yanaba K, …, Fujimoto M, Tedder TF
J Clin Invest 2008 Oct 118(10):3420-30 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Stefan Martin
Evaluated 12 Oct 2008

Recommended
F1000 Factor 3.0

Confirmation
Controversial
Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
Firooz A, Ghandi N, …, Valikhani M, Karbakhsh Davari M
Arch Dermatol 2008 Sep 144(9):1143-7 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Aimee Payne
Evaluated 3 Oct 2008

Must Read
F1000 Factor 6.0

New Finding
B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses.
Mouquet H, Musette P, …, Tron F, Joly P
J Invest Dermatol 2008 Jun 19 [abstract on PubMed] [related articles] [full text]
Selected by | Yumi Aoyama
Evaluated 25 Sep 2008

Recommended
F1000 Factor 3.0

Confirmation
Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect.
Mul VE, van Geest AJ, …, Lambin P, Baumert BG
Radiother Oncol 2007 Jan 82(1):5-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Dedee Murrell with Supriya Venugopal
Evaluated 25 Sep 2008

Recommended
F1000 Factor 3.0

New Finding
Development of an IgG4-Based Predictor of Endemic Pemphigus Foliaceus (Fogo Selvagem).
Qaqish BF, Prisayanh P, …, Rivitti EA, Diaz LA
J Invest Dermatol 2008 Aug 14 [abstract on PubMed] [related articles] [full text]
Selected by | Aimee Payne
Evaluated 24 Sep 2008

Recommended
F1000 Factor 3.0

Confirmation
Mucous membrane pemphigoid: are laminin 5 antibodies a risk factor for laryngeal involvement?
Shipman A, Ali I, Murrell D, Wojnarowska F
J Eur Acad Dermatol Venereol 2008 Aug 27 [abstract on PubMed] [related articles] [full text]
Selected by | Marcel Jonkman
Evaluated 23 Sep 2008

Recommended
F1000 Factor 3.0

New Finding
Immunofluorescence Analysis of Villous Trophoblasts: A Tool for Prenatal Diagnosis of Inherited Epidermolysis Bullosa with Pyloric Atresia.
D'Alessio M, Zambruno G, …, Lacour JP, Meneguzzi G
J Invest Dermatol 2008 Jun 19 [abstract on PubMed] [related articles] [full text]
Selected by | Johann Bauer with Martin Laimer
Evaluated 10 Sep 2008

Must Read
F1000 Factor 6.0

New Finding
T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris.
Takahashi H, Amagai M, …, Kawakami Y, Kuwana M
J Invest Dermatol 2007 Feb 127(2):324-30 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Cassian Sitaru
Evaluated 10 Sep 2008

Must Read
F1000 Factor 4.9

Hypothesis
New Finding
Loss of desmocollin 3 in mice leads to epidermal blistering.
Chen J, Den Z, Koch PJ
J Cell Sci 2008 Sep 1 121(Pt 17):2844-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Marcel Jonkman with Marieke Bolling / Aimee Payne / Takashi Hashimoto
First evaluation 21 Aug 2008 | Latest evaluation 4 Sep 2008

Recommended
F1000 Factor 3.0

New Finding
A pilot quality-of-life instrument for pruritus.
Desai NS, Poindexter GB, …, Swerlick RA, Chen SC
J Am Acad Dermatol 2008 Aug 59(2):234-44 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Dedee Murrell with Deshan Sebaratnam
Evaluated 8 Aug 2008


top of pagePage 1 of 4. Select Page: 1 2 3 4 >>
Display 10 / 20 / 50 papers per page


© 2008 Medicine Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info